NCT02005341撤回不适用
A Prospective, Nonrandomized Study to Assess Lumbar Fusion With Instrumented Posterolateral Gutter Fusions Using NanOss Bioactive
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 主要终点
- Fusion at 12 months postoperatively.
研究概览
简要总结
The purpose of this study is to assess lumbar fusion using nanOss Bioactive bone void filler
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Is at least 21 years of age and skeletally mature.
- •Must have cervical disc disease (defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies) at one level in the cervical spine between C3 to T
- •Must have completed a minimum of six weeks of unsuccessful conservative, non-operative care or has the presence of progressive symptoms or signs of nerve root/spinal cord compression in the face of conservative treatment.
- •Has pre-operative objective evidence of primary diagnosis confirmed by appropriate imaging studies (Anteroposterior/Lateral/Flexion/Extension X-rays & a recent MRI).
- •Is willing and able to comply with all clinical investigation visits and procedures including screening treatment procedures, post-operative management, the follow-up schedule and completion of forms or questionnaires.
- •Is able to understand and sign the patient information sheet/informed consent form.
排除标准
- •Requires fusion at more than one level.
- •Has had prior fusion at the level to be treated.
- •Has a metabolic or systemic bone disorder.
- •Has a disease that significantly inhibits bone healing (i.e., severe osteoporosis, osteomalacia, Paget's disease).
- •Has a systemic or local infection (active or latent).
- •Has acute or chronic infections in the surgical area (i.e., soft tissue infections; inflammatory, bacterial bone disorders, osteomyelitis).
- •Chronic use of steroids, other than episodic use or inhaled corticosteroids.
- •Has any significant general illness (i.e., HIV, active metastatic cancer of any type, uncontrolled diabetes Type I, dialysis dependent renal failure, symptomatic liver disease).
- •Has a mental or physical condition that would limit the ability to comply with study requirements or would preclude accurate evaluation.
- •Is immunocompromised or being treated with immunosuppressive agents (including chemotherapy or radiation treatment).
- •Has documented allergies to hydroxyapatite or porcine collagen, PEEK, titanium, titanium alloy or tantalum.
- •Is currently pregnant, or interested in becoming pregnant during the clinical investigation follow-up.
- •Is a smoker.
- •Is non-English speaking.
- •Requires the use of a bone-growth stimulator.
- •Is a prisoner.
- •Is currently involved in another drug or device clinical investigation that may confound the clinical trial investigation
结局指标
主要结局
Fusion at 12 months postoperatively.
时间窗: 12 months
次要结局
未报告次要终点
研究者
相似试验
招募中
不适用
OssiMend BA in Posterolateral Instrumented Lumbar FusionSpinal DiseaseDegenerative Disc DiseaseNCT04775537Collagen Matrix120
已完成
不适用
Comparison of nanOss Bioactive With Autograft and Bone Marrow Aspirate to Autograft in the Posterolateral SpineSpondylolisthesisDegenerative Disc DiseaseSpinal StenosisNCT01968993Pioneer Surgical Technology, Inc.24
进行中（未招募）
不适用
Adaptix RCT Evaluating Adaptix™ Versus PEEK CagesSpinal Canal StenosisOsteophyteBony Growth FormationSpondylolisthesisDegenerative Disc DiseaseNCT05182489Ohio State University100
已完成
不适用
Lumbar Fusion With Nexxt Spine 3D-Printed Titanium Interbody CagesLumbar Degenerative Disc DiseaseLumbar SpondylolisthesisLumbar Spinal DeformityLumbar SpondylosisLumbar Spinal StenosisNCT03647501Ohio State University53
进行中（未招募）
不适用
Efficacy and Safety of Novosis Putty for Degenerative Lumbar DiseaseDegenerative Lumbar DiseasesNCT06715345CGBio Inc.48